• United Kingdom

Accepting PhD Students

PhD projects

(1) Evaluating the nuclear import pathway as a druggable target for cancer therapy (Self-funded)
(2) Scalability of polymeric delivery system characteristics (Self-funded)
(3) Developing new analytical pipelines for profiling the nanoparticle corona proteome
(4) Understanding the drivers of rheumatic disease outcomes in patient populations

Network

Panida Punnabhum

  • SIPBS, Strathclyde Inst Pharm & Biomed Sci
  • Department of Pure and Applied Chemistry

External person

Alain Pluen

  • University of Manchester
  • University of Manchester

External person

Caroline H. Johnson

  • Scripps Research Institute
  • Yale University

External person

Caterina Minelli

  • National Physical Laboratory NPL

External person

Alison Lannigan

  • NHS Lanarkshire

External person

Caroline Johnson

  • Yale University

External person

Egor Zindy

  • University of Manchester

External person

Yuping Cai

  • Yale University

External person

Carmel Moran

  • School of Clinical Sciences, University of Edinburgh
  • Edinburgh University

External person

Tomas Jansson

  • Department of Clinical Sciences Lund, Biomedical Engineering, Lund University, Lund, Sweden

External person

Yawei Zhang

  • Yale University

External person

Susan Moug

  • NHS GREATER GLASGOW AND CLYDE

External person

Susan Farrington

  • MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh

External person

Yiwen Pei

  • National Physical Laboratory NPL

External person

Adrian Thomson

  • BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, U.K.

External person

Vladimir Densiov

  • Department of Clinical Sciences Lund, Biomedical Engineering, Lund University, Lund, Sweden

External person

Philip B. Paty

  • Memorial Sloan-Kettering Cancer Center

External person

Yasmin Hunter

  • SIPBS, Strathclyde Inst Pharm & Biomed Sci

External person

Hwei Jene Ng

  • NHS SCOTLAND

External person

James Hansen

  • Yale University School of Medicine

External person

David Clarke

  • University of Manchester

External person

Drupad K Trivedi

  • University of Manchester
  • University of Manchester

External person

Shona McKirdy

  • University of Glasgow

External person

Mitul Patel

  • GSK, Stevenage

External person

William Lewis

  • GSK, Stevenage

External person

Kuo Shun Hsu

  • Memorial Sloan-Kettering Cancer Center

External person

Ricky Casey

  • GSK, Stevenage

External person

Qian Zhang

  • Yale University
  • The University of Queensland

External person

Abdullah Al Sultan

  • University of Strathclyde
  • Department of Pure and Applied Chemistry
  • Kuwait University

External person

Richard Hansen

  • University of Glasgow

External person

David Clarke

  • University of Manchester

External person

Paula Sanches

  • GSK, Stevenage

External person

Alvaro Santos-Neto

  • Yale University

External person

Varvara Mironova

  • Yale University

External person

Sajid A. Khan

  • Yale University School of Medicine

External person

Eeva-Liisa Eskelinen

  • University of Turku

External person

Cian Monnin

  • McGill University

External person

Jun Liu

  • Harbin Engineering University

External person

Jessica Lasky-Su

  • Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

External person

Yun Xu

  • University of Manchester
  • University of Manchester

External person

Nicholas Rattray

  • University of Manchester

External person

Katie Day

  • MedImmune Ltd

External person

Ivan Topisirovic

  • McGill University

External person

Konstantinos Gerasimidis

  • UNIVERSITY OF GLASGOW

External person

Leigh Connor

  • Diamond Light Source, Harwell Science and Innovation Campus

External person

Stephen J Fowler

  • University of Manchester
  • Lancashire Teaching Hospitals NHS Foundation Trust
  • Faculty of Biology, Medicine and Health
  • University of Manchester
  • Central Manchester University Hospitals NHS Foundation Trust

External person

Nita Ahuja

  • Yale University School of Medicine

External person

Zoe Apczynski

  • SIPBS, Strathclyde Inst Pharm & Biomed Sci

External person

Lingeng Lu

  • Yale University

External person

Royston Goodacre

  • Manchester Institute of Biotechnology
  • University of Manchester
  • University of Manchester
  • University of Liverpool
  • University of Liverpool
  • University of Manchester

External person

Run Zeng

  • Queens University

External person

Dana Avizonis

  • McGill University

External person

Gary Siuzdak

  • Scripps Research Institute

External person

Morag Ross

  • SIPBS, Strathclyde Inst Pharm & Biomed Sci

External person

Malgorzata Tracka

  • MedImmune Ltd

External person

Dean Murphy

  • AstraZeneca, Macclesfield

External person

Zeming Chen

  • Yale University School of Medicine

External person

Jun Lu

  • Yale University School of Medicine

External person

David Jones

  • GSK, Stevenage

External person

Iain R. White

  • University of Nova Gorica
  • Faculty of Biology, Medicine and Health

External person

Sebastian Oeck

  • University of Essen

External person

Justin R. Cross

  • Memorial Sloan-Kettering Cancer Center

External person

Katie Tingey

  • MedImmune Ltd

External person

Kaylee Punter

  • Queens University

External person

Huang Huang

  • Yale University

External person

Sarah Irvine

  • Diamond Light Source, Harwell Science and Innovation Campus

External person

Xinyi Shen

  • Yale University

External person

Nathalie Malewicz

  • Ruhr-Universität Bochum

External person

Yamini Arthanari

  • University of Manchester

External person

Claire Patterson

  • AstraZeneca, Macclesfield

External person

Avi Schroeder

  • Technion - Israel Institute of Technology

External person

Hayley McGlynn

  • University of Manchester

External person

Richard Russell

  • University of Glasgow

External person

Robin Curtis

  • University of Manchester

External person

Lisa van den Driest

  • Strathclyde Institute of Pharmacy and Biomedical Sciences

External person

shahid uddin

  • MedImmune Ltd

External person

Shahid Uddin

  • MedImmune Ltd

External person

Harmesh Aojula

  • University of Manchester

External person

Sheela Abraham

  • Queens University

External person

Hong Yan

  • Yale University

External person

Chelsea Margerum

  • Queens University

External person

Vicente Escamilla-Rivera

  • University of Arizona

External person

Naser F. Al-Tannak

  • Strathclyde Institute of Pharmacy and Biomedical Science
  • Kuwait University

External person

Casey Theriot

  • North Carolina State University

External person

Burcu Binici

  • University of Strathclyde

External person

Myasar Alkotaji

  • University of Manchester

External person

Robert La Motte

  • Yale University School of Medicine

External person

Jiangbing Zhou

  • Yale University School of Medicine

External person

Jeffrey Penny

  • University of Manchester

External person

Sebastian Jung

  • Ruhr-Universität Bochum

External person

David Papadopoli

  • McGill University

External person

Patricia Gaule

  • Yale University School of Medicine

External person

Sajid Khan

  • Yale University School of Medicine

External person

Maryam Hussain

  • University of Manchester

External person

Benedikt Warth

  • Scripps Research Institute
  • Institut fur Analysis und Scientific Computing, Technische Universitat Wien A-1040 Wien

External person

Royston Goodacre

  • University of Manchester

External person

Engjel Muca

  • Memorial Sloan-Kettering Cancer Center

External person

Charles Chu

  • Queens University

External person